(Q36081871)

12 August 2017

Potential for cost economies in guiding therapy in patients with metastatic breast cancer (English)

1 reference

12 August 2017

metastatic breast cancer

1 reference

Robertson JF

1

1 reference

12 August 2017

Whynes DK

series ordinal

2

1 reference

12 August 2017

Dixon A

series ordinal

3

1 reference

12 August 2017

Blamey RW

series ordinal

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 July 1995

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

72

1 reference

12 August 2017

1

1 reference

12 August 2017

174-177

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1995.297

12 August 2017

0 references

cites work

Advanced breast cancer: use of resources and cost implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034118

Chemotherapy of advanced breast cancer: outcome and prognostic factors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034118

Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034118

An evaluation of mucin-like carcinoma associated antigen (MCA) in breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034118

An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034118

Use of mucin like cancer associated antigen (MCA) in the management of breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034118

The cost of breast cancer recurrences

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034118

Advanced breast cancer and its prevention by screening

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034118

Objective measurement of therapeutic response in breast cancer using tumour markers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034118

Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034118

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

11 July 2018

1 reference

12 December 2020

Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy

1 reference

12 December 2020

Long-chain aliphatic fatty acids and phytanic acid simultaneously measured by dual-column capillary chromatography

1 reference

12 December 2020

Assessment of four monoclonal antibodies as serum markers in breast cancer

1 reference

12 December 2020

Prospective assessment of the role of five tumour markers in breast cancer

1 reference

12 December 2020

Serological monitoring of advanced breast cancer treated by systemic cytotoxic using a combination of ESR, CEA, and CA 15.3: fact or fiction?

1 reference

12 December 2020

CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.297

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

7599049

1 reference